Publication | Closed Access
Gefitinib Versus Gefitinib Plus Pemetrexed and Carboplatin Chemotherapy in <i>EGFR</i>-Mutated Lung Cancer
415
Citations
30
References
2019
Year
Adding pemetrexed and carboplatin chemotherapy to gefitinib significantly prolonged PFS and OS but increased toxicity in patients with NSCLC.
| Year | Citations | |
|---|---|---|
Page 1
Page 1